Cargando…

Economic and clinical burden of viral hepatitis in California: A population-based study with longitudinal analysis

BACKGROUND: Economic burden of HBV and HCV infection are trending upwards. AIMS: Compare hepatitis B virus (HBV) and hepatitis C virus (HCV) related hospital admission rates, charges, mortality rates, causes of death in a US population-based study. METHODS: Retrospective cohort analysis of HBV and H...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Haesuk, Jeong, Donghak, Nguyen, Pauline, Henry, Linda, Hoang, Joseph, Kim, Yoona, Sheen, Edward, Nguyen, Mindie H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5927421/ https://www.ncbi.nlm.nih.gov/pubmed/29708985 http://dx.doi.org/10.1371/journal.pone.0196452

Ejemplares similares

Correction: Economic and clinical burden of viral hepatitis in California: A population-based study with longitudinal analysis
por: Park, Haesuk, et al.
Publicado: (2018)

Higher mortality and hospital charges in patients with cirrhosis and acute respiratory illness: a population-based study
por: Zou, Biyao, et al.
Publicado: (2018)

Racial/ethnic- and county-specific prevalence of chronic hepatitis B and its burden in California
por: Toy, Mehlika, et al.
Publicado: (2018)

Diagnosis Rates of Chronic Hepatitis B in Privately Insured Patients in the United States
por: Ogawa, Eiichi, et al.
Publicado: (2020)

Physician perspectives on the management of viral hepatitis and hepatocellular carcinoma in Myanmar
por: Kim, Yoona A., et al.
Publicado: (2017)

Economic Burden of Sanfilippo Syndrome in the United States
por: Ashby, Frederick, et al.
Publicado: (2023)

Impact of All‐Oral Direct‐Acting Antivirals on Clinical and Economic Outcomes in Patients With Chronic Hepatitis C in the United States
por: Park, Haesuk, et al.
Publicado: (2019)

Barriers to care for chronic hepatitis C in the direct-acting antiviral era: a single-centre experience
por: Nguyen, Peter, et al.
Publicado: (2017)

Rate of hepatocellular carcinoma surveillance remains low for a large, real-life cohort of patients with hepatitis C cirrhosis
por: Tran, Sally Ann, et al.
Publicado: (2018)

Racial Disparities in Treatment Rates for Chronic Hepatitis C: Analysis of a Population-Based Cohort of 73,665 Patients in the United States
por: Vutien, Philip, et al.
Publicado: (2016)

Screening and management of viral hepatitis and hepatocellular carcinoma in Mongolia: results from a survey of Mongolian physicians from all major provinces of Mongolia
por: Kim, Yoona A, et al.
Publicado: (2016)

Economic burden of lives lost due to COVID-19 in California State
por: Zheng, Michelle, et al.
Publicado: (2022)

Increasing co-morbidities in chronic hepatitis B patients: experience in primary care and referral practices during 2000–2015
por: Liu, Anne, et al.
Publicado: (2018)

Characteristics and Treatment Rate of Patients With Hepatitis C Virus Infection in the Direct-Acting Antiviral Era and During the COVID-19 Pandemic in the United States
por: Nguyen, Vy H., et al.
Publicado: (2022)

Burden of fatal drowning in California, 2005–2019
por: Koon, William, et al.
Publicado: (2023)

Higher risk of hepatocellular carcinoma in Hispanic patients with hepatitis C cirrhosis and metabolic risk factors
por: Wong, Alina, et al.
Publicado: (2018)

Tenofovir alafenamide in the treatment of chronic hepatitis B: design, development, and place in therapy
por: Ogawa, Eiichi, et al.
Publicado: (2017)

Burden of injuries in Vietnam: emerging trends from a decade of economic achievement
por: Nguyen, Quynh Anh, et al.
Publicado: (2020)

Economic burden of hepatitis B infection among patients with diabetes
por: Deshpande, Gaurav, et al.
Publicado: (2016)

The Economic Burden of Chronic Kidney Disease in Vietnam
por: Nguyen-Thi, Hai-Yen, et al.
Publicado: (2021)

Autoantibodies in chronic hepatitis C virus infection: impact on clinical outcomes and extrahepatic manifestations
por: Gilman, Andrew J, et al.
Publicado: (2018)

Transient Elastography and Serum-Based Tests for Diagnosis of Fatty Liver and Advanced Fibrosis in a Community Cohort: A Cross-Sectional Analysis
por: Le, Michael H., et al.
Publicado: (2022)

Economic burden of Thalassemia treatment: An analysis from the Vietnam Social Security perspective
por: Nhac-Vu, Hoang-Thy, et al.
Publicado: (2023)

Nonalcoholic Fatty Liver Disease and Renal Function Impairment: A Cross‐Sectional Population‐Based Study on Its Relationship From 1999 to 2016
por: Le, Michael H., et al.
Publicado: (2019)

Real-world experience with interferon-free, direct acting antiviral therapies in Asian Americans with chronic hepatitis C and advanced liver disease
por: Chang, Christine Y., et al.
Publicado: (2017)

Regional differences in treatment rates for patients with chronic hepatitis C infection: Systematic review and meta-analysis
por: Vutien, Philip, et al.
Publicado: (2017)

Economic burden of venous thromboembolism in surgical patients: A propensity score analysis from the national claims database in Vietnam
por: Bui, My Hanh, et al.
Publicado: (2020)

High Prevalence of Chronic Viral Hepatitis and Liver Fibrosis among Mongols in Southern California
por: Fong, Tse-Ling, et al.
Publicado: (2020)

The economic burden of cancers attributable to smoking in Korea, 2014
por: Nguyen, Thi Xuan Trinh, et al.
Publicado: (2019)

Economic Burden Attributed to Children Presenting to Hospitals With Hand, Foot, and Mouth Disease in Vietnam
por: Nhan, Le Nguyen Thanh, et al.
Publicado: (2019)

Hepatitis E Virus in Rats, Los Angeles, California, USA
por: Purcell, Robert H., et al.
Publicado: (2011)

Burden of unmet health-related social needs in an academic adult primary care practice in San Francisco California
por: Jih, Jane, et al.
Publicado: (2023)

Burden of Acute Viral Hepatitis — China, 1990−2019
por: Yu, Shicheng, et al.
Publicado: (2020)

Poor adherence and low persistency rates for hepatocellular carcinoma surveillance in patients with chronic hepatitis B
por: Wang, Christina, et al.
Publicado: (2016)

Direct‐Acting Antiviral Treatment Use Remains Low Among Florida Medicaid Beneficiaries With Chronic Hepatitis C
por: Park, Haesuk, et al.
Publicado: (2020)

Re-treatment of patients with chronic hepatitis C virus genotype 4 infection with pegylated interferon and ribavirin: a meta-analysis
por: Zhang, Bing, et al.
Publicado: (2015)

Chronic hepatitis C virus (HCV) increases the risk of chronic kidney disease (CKD) while effective HCV treatment decreases the incidence of CKD
por: Park, Haesuk, et al.
Publicado: (2017)

Trends in anemia care in non-dialysis-dependent chronic kidney disease (CKD) patients in the United States (2006–2015)
por: Park, Haesuk, et al.
Publicado: (2018)

Modeling the Health and Economic Burden of Hepatitis C Virus in Switzerland
por: Müllhaupt, Beat, et al.
Publicado: (2015)

The Estimation of Economic Burden of Hepatitis C Virus Infection in Iran
por: MOHAMMADZADEH, Mehdi, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_v85unic6uoac7f9m8i6v78onfo